SCHEMBL4904159

SCHEMBL4904159

CCN(c1nc(-c2ccc(Cl)cc2)sc1C)S(=O)(=O)c1ccc(Cl)c(C(=O)O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
LMNA P02545 5/20 0.43
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
RAB9A P51151 1/20 0.41
GAA P10253 1/20 0.41
ALDH1A1 P00352 6/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TSHR P16473 1/20 0.40
MAPT P10636 2/20 0.39
TRPM8 Q7Z2W7 1/20 0.39
HTT P42858 1/20 0.39
PTPN22 Q9Y2R2 1/20 0.39
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902506 0.92 LMNA (0.43) MEN1KMT2ALMNAKDM4ESMN1; SMN2
SCHEMBL4902748 0.92 LMNA (0.48) MEN1KMT2ALMNAKDM4EGAA
SCHEMBL4904475 0.91 LMNA (0.42) MEN1KMT2ALMNAKDM4ESMN1; SMN2
SCHEMBL4894397 0.90 MEN1 (0.49) MEN1KMT2ALMNAKDM4EGAA
SCHEMBL4904036 0.90 ALDH1A1 (0.54) MEN1KMT2ALMNAKDM4ESMN1; SMN2
SCHEMBL4904191 0.89 LMNA (0.42) MEN1KMT2ALMNAKDM4ESMN1; SMN2
SCHEMBL4904359 0.88 KDM4E (0.40) MEN1KMT2ALMNAKDM4ESMN1; SMN2
SCHEMBL4907121 0.85 LMNA (0.47) MEN1KMT2ALMNAALDH1A1HPGD
SCHEMBL4905616 0.84 LMNA (0.46) MEN1KMT2ALMNAALDH1A1HPGD
SCHEMBL4901463 0.84 ALDH1A1 (0.44) MEN1KMT2ALMNAKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885LMNA 319/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MEN1 4855/4885KMT2A 3530/4885LMNA 319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.